TGFB1 and type 2 diabetes mellitus: As previously reported, despite the presence of increased serum levels of TGF-β in SCZ [71] and T2DM patients [72], no significant modulation or, more strikingly, a downregulation in the expression of this cytokine can be observed in PBMCs [73,74].